股本结构
单位：万股
| 公告日期 | 2023-03-28 | 2023-03-28 | 2022-11-14 | 2022-11-14 | 2022-08-23 | 2022-08-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 7333.26 | 7332.50 | 7303.35 | 7298.35 | 7294.67 | 7259.14 |
| 普通股本 | 7333.26 | 7332.50 | 7303.35 | 7298.35 | 7294.67 | 7259.14 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2023-03-24 | 2022-12-31 | 2022-11-11 | 2022-09-30 | 2022-08-19 | 2022-08-12 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2023-03-28 | 7333.26 | 未披露 | 定期报告 | 2023-03-24 |
| 2023-03-28 | 7332.50 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Exercise of warrants
Issuance of commitment shares
Sale of common stock, net of issuance costs
Merger recapitalization
Proceeds from Business Combination, net of issuance costs and assumed liabilities
Release of restricted stock units
Conversion of redeemable convertible preferred stock into common stock upon merger recapitalization
Exercise of stock options
|
2022-12-31 |
| 2022-11-14 | 7303.35 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 7298.35 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Release of restricted stock units
Issuance of common stock commitment shares
Sale of common stock, net of commissions
|
2022-09-30 |
| 2022-08-23 | 7294.67 | 未披露 | 定期报告 | 2022-08-19 |
| 2022-08-15 | 7259.14 | 未披露 | 定期报告 | 2022-08-12 |
| 2022-08-15 | 7255.25 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
|
2022-06-30 |
| 2022-06-08 | 7243.76 | 未披露 | 定期报告 | 2022-06-07 |
| 2022-05-12 | 7239.04 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Conversion of Legacy Gelesis convertible preferred stock into common stock upon Business Combination
Proceeds from Business Combination, net of issuance costs and assumed liabilities
Stock based compensation expense Exercise of warrants
Accretion of Legacy Gelesis senior preferred stock to redemption value prior to Business Combination
|
2022-03-31 |
| 2022-01-20 | 7221.43 | 未披露 | 定期报告 | 2022-01-14 |
| 2020-11-13 | 3450.00 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Sale of 27,600,000 Units, net of underwriting discounts
Common stock subject to possible redemption
|
2020-09-30 |
| 2020-08-17 | 3450.00 | 未披露 | 定期报告 | 2020-08-24 |
From December 31, 2021 to December 31, 2022
Exercise of warrants
Issuance of commitment shares
Sale of common stock, net of issuance costs
Merger recapitalization
Proceeds from Business Combination, net of issuance costs and assumed liabilities
Release of restricted stock units
Conversion of redeemable convertible preferred stock into common stock upon merger recapitalization
Exercise of stock options
From June 30, 2022 to September 30, 2022
Release of restricted stock units
Issuance of common stock commitment shares
Sale of common stock, net of commissions
From March 31, 2022 to June 30, 2022
Issuance of common stock upon exercise of stock options
From December 31, 2021 to March 31, 2022
Conversion of Legacy Gelesis convertible preferred stock into common stock upon Business Combination
Proceeds from Business Combination, net of issuance costs and assumed liabilities
Stock based compensation expense Exercise of warrants
Accretion of Legacy Gelesis senior preferred stock to redemption value prior to Business Combination
From June 30, 2020 to September 30, 2020
Sale of 27,600,000 Units, net of underwriting discounts
Common stock subject to possible redemption